"Patients seen at this location for maternity services will deliver at the Hospital of the University of Pennsylvania."

During the past decade, Penn OB/GYN Associates conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Penn OB/GYN Associates" #1 collaborator was "Bayer Droegemueller Award in Clinical Research" with 1 trials as a collaborator and "Burroughs Wellcome" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Penn OB/GYN Associates" are "Breast Cancer" (1 trials) and "Preterm Birth" (1 trials). Many other conditions were trialed in "Penn OB/GYN Associates" in a lesser frequency.

Most popular intervention types in "Penn OB/GYN Associates" are "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Breast Cancer Screening Decision Aid" (1 trials). Other intervention names were less common.

The vast majority of trials in "Penn OB/GYN Associates" are 2 trials for "Female" genders.

Currently, there are NaN active trials in "Penn OB/GYN Associates". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Penn OB/GYN Associates, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Penn OB/GYN Associates, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".